Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison

Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison

Abstract Background Classical homocystinuria (HCU), an inborn error of homocysteine metabolism, has previously been estimated to affect approximately 1 in 100,000–200,000 people in the United States (US). HCU is poorly detected by newborn screening, resulting in underestimates of its prevalence. Thi...

Full description

Bibliographic Details
Main Authors: Marcia Sellos-Moura, Frank Glavin, David Lapidus, Kristin Evans, Carolyn R. Lew, Debra E. Irwin
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Health Services Research
Subjects:
Homocysteine
Homocystinuria
Phenylketonuria
Prevalence
Costs
Utilization
Online Access:http://link.springer.com/article/10.1186/s12913-020-5054-5

Internet

http://link.springer.com/article/10.1186/s12913-020-5054-5

Similar Items